Navigation Links
The Conference Forum Announces A New Medicaid Rebate Summit for Early 2013
Date:12/19/2012

New York, New York (PRWEB) December 19, 2012

The Conference Forum, recognized in the pharmaceutical industry for its interactive-style meetings, announced a new conference to navigate the complexities of the Medicaid Rebate process. The Medicaid Rebate Summit brings manufacturers together with State Medicaid and Pharmacy leaders to work through the interpretation of the anticipated Final Rule, the larger implications of health care reform and its financial and operational impact as well as resolutions for disputes.

Alice Valder Curran of Hogan Lovells opens the program with remarks on interpreting the Final Rule – a “hot” topic for 2013. The 2013 Medicaid Rebate Summit fosters relationships between drug manufactures and state agencies in order to better serve the Medicaid population. Attendees will:

  • Hear pertinent Health Care Association insights on health care reform and POVs from Managed Markets, Government Contracting, Pricing and Reimbursement, States and Consultants.
  • Participate in a Q&A with CMS representation lead by LaDonna Steiner of Purdue Pharma.

The conference has two track choices to allow individual event customization. Track One, chaired by Heather Dixson, Director Government Price Reporting, Eli Lilly & Co will address interpretation and implementation of the Final Rule. Track Two, chaired by Ed McAdam, Senior Director, Pricing & Analytics, Daiichi Sankyo, Inc. will focus on 340B, Government Pricing and Reimbursement.

When speaking about his involvement McAdams said, “With all of the pending changes around government pharmaceutical programs this conference brings together leading industry and government experts all in one place to provide you with valuable insight into the future.”

Event Details:

Medicaid Rebate Summit
Date: February 14-15, 2013
Location: Park Hyatt Washington, Washington, DC
Click here to register.

Pre-Conference Medicaid Rebate Bootcamp
The workshop is designed for professionals either new to the Medicaid Rebate space or
for those looking for a refresher course on the basics.
Date: February 13, 2013
Location: Park Hyatt Washington, Washington, DC
Click here to register.

For program details click here
Questions, please email service(at)theconferenceforum(dot)org

Speakers Include:

  • Derek Asay, Eli Lilly & Co.
  • George Bilyk, Janssen
  • JoAnn Bute, Amneal Pharmaceuticals
  • Kevin Cast, Express Scripts
  • Chris Cobourn, CIS
  • Cori Cooper, PharmD, Wyoming Department of Health
  • Thomas Corcoran, Assistant US Attorney, District of Maryland
  • John Coster, PhD, RPh, National Community Pharmacists Association
  • Alice Valder Curran, Hogan Lovells
  • Tarra DeShields, Assistant U.S. Attorney, Civil Division, District of Maryland
  • Heather Dixson Eli Lilly & Co.
  • Audrey Fletcher, CIS
  • Sharon Greeson, RPh, HP
  • Edmund Haislmaier, Heritage Foundation
  • Christopher A. Hatwig, MS, RPh, FASHP, APEXUS/ 340B Prime Vendor
Program
  • Mike Hepburn, Janssen R&D, LLC
  • Rich Holsapple, RPh, Oregon MMIS, HP Enterprise Services
  • Christopher Jackson, Bayer HealthCare LLC
  • Ann Kaplan, PhRMA
  • Julie Khani, National Association of Chain Drug Stores
  • Mitch Lazris, Hogan Lovells
  • Lori Martin, Eli Lilly & Co.
  • Paula Martins, Daiichi Sankyo, Inc.
  • Jesse Mensah, Celgene
  • Ed McAdam, Daiichi Sankyo, Inc.
  • Lisa McNair, Reckitt Benckiser
  • Jennifer Norton, Vertex Pharmaceuticals, Inc.
  • Brian Osberg, National Governors Association
  • Viveca Parker, Assistant US Attorney, Civil Division United States,
Eastern District of PA
  • DR Krista Pedley, HRSA Office of Pharmacy Affairs
  • Erica Petersohn, CIS
  • Bill Phillips, CIS
  • Joann S. Prushinski, Genentech, Inc.
  • Kent Rogers, MBA, Acorda Therapeutics
  • Matt Sheffield, Boehringer Ingelheim Pharmaceuticals, Inc.
  • LaDonna Steiner, Purdue Pharma
  • Laurel Todd, MBA, BIO

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10231551.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference
2. EastBridge Investment Group and CBMG attended SeeThruEquity Investor Conference in New York
3. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
6. Pinnaclife Animal Health to attend CVC Conference in San Diego
7. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
8. Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
9. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
10. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, ... could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma ... read it now. , Biomarkers are components in the blood, tissue or ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
Breaking Biology News(10 mins):